Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

A Chimeric Gene, FIP1L1-RARα, Is Isolated from t(4;17)-Positive Acute Promyelocytic Leukemia; a Report of Cloning and Functional Analysis.

Takeshi Kondo, MD, PhD, Akio Mori, MD, PhD, Masahiro Onozawa, MD, PhD, Kaoru Kahata, MD, PhD, Satoshi Hashino, MD, PhD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Masanobu Morioka, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2007) 110 (11): 1820.

https://doi.org/10.1182/blood.V110.11.1820.1820

Published: 2007

Journal Articles

Donor-Type Myelodysplastic Syndrome with t(2;3) and Monosomy 7 after Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-Type Aplastic Anemia.

Satoshi Hashino, MD, PhD, Fumie Fujisawa, MD, Takeshi Kondo, MD, PhD, Masahiro Imamura, MD, PhD, Kazuya Sato, MD, PhD, Yoshihiro Torimoto, MD, PhD, Yutaka Kohgo, MD, PhD, Keisuke Kimura, MD, PhD, Hiroyuki Furukawa, MD, PhD, Satoru Todo, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2006) 108 (11): 5357.

https://doi.org/10.1182/blood.V108.11.5357.5357

Published: 2006

Journal Articles

HBV Reverse Seroconversion and Intervention with Vaccination after Allogeneic HSCT in Patients with Previous HBV Infection.

Masahiro Onozawa, MD, Hiroe Kanamori, MD, Kaoru Kahata, MD, Takeshi Kondo, MD,PhD, Shuichi Ota, MD,PhD, Satoshi Hashino, MD,PhD, Junji Tanaka, MD,PhD, Masahiro Imamura, MD,PhD, Masahiro Asaka, MD,PhD

Blood (2006) 108 (11): 2921.

https://doi.org/10.1182/blood.V108.11.2921.2921

Published: 2006

Journal Articles

Chimeric Leukemic Protein PLZF/RARα Functions as an Adoptor for Cul3-Based E3 Ubiquitin Ligase To Regulate Proteosomal Degradation of RXRα.

Masahiro Onozawa, MD, Takeshi Kondo, MD, PhD, Hiroe Kanamori, MD, Kaoru Kahata, MD, PhD, Satoshi Hashino, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2006) 108 (11): 1926.

https://doi.org/10.1182/blood.V108.11.1926.1926

Published: 2006

Journal Articles

Clinical Efficacy and Cost Benefit of Low-Dose Granulocyte Colony-Stimulating Factor after Standard Chemotherapy in Patients with Non-Hodgkin’s Lymphoma.

Satoshi Hashino, MD, PhD, Masanobu Morioka, MD, PhD, Tatsuro Irie, MD, PhD, Noriyuki Shiroshita, MD, PhD, Tsugumichi Kawamura, MD, PhD, Sachiko Suzuki, MD, PhD, Hiroshi Iwasaki, MD, PhD, Shintaro Umehara, MD, PhD, Yasutaka Kakinoki, MD, PhD, Mitsutoshi Kurosawa, MD, PhD, Kaoru Kahata, MD, PhD, Koh Izumiyama, MD, PhD, Hajime Kobayashi, MD, Masahiro Onozawa, MD, Mutsumi Takahata, MD, Fumie Fujisawa, MD, Takeshi Kondo, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2006) 108 (11): 4671.

https://doi.org/10.1182/blood.V108.11.4671.4671

Published: 2006

Journal Articles

Expansion of Inhibitory NK Receptor (CD94/NKG2A)-Expressing Cytolytic CD8 T Cells and CD4 + CD25 + Regulatory T Cells from the Same Cord Blood.

Junji Tanaka, MD, PhD, Junichi Sugita, MD, Naoko Kato, MD, PhD, Tomomi Toubai, MD, PhD, Jun Ibata, MD, Yusuke Shono, MD, Shuichi Ota, MD, PhD, Masahiro Asaka, MD, PhD, Masahiro Imamura, MD, PhD

Blood (2006) 108 (11): 1739.

https://doi.org/10.1182/blood.V108.11.1739.1739

Published: 2006

Journal Articles

Transition of Humoral Immunity and Clinical VZV Reactivation in Hematopoietic Stem Cell Transplantation Recipients.

Masahiro Onozawa, MD, Satoshi Hashino, MD, PhD, Takeshi Kondo, MD, PhD, Shuichi Ota, MD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2005) 106 (11): 5352.

https://doi.org/10.1182/blood.V106.11.5352.5352

Published: 2005

Journal Articles

Analysis of TREC (T Cell Receptor Excision Circles) Levels in CD94 Expressing CD8 T Cells in Chronic GVHD.

Noriaki Iwao, MD, Junji Tanaka, MD, Naoko Kato, MD, Takeshi Kondo, MD, Yoko Miura, MD, Tomomi Toubai, MD, Akio Shigematsu, MD, Keiichi Kondo, MD, Shuichi Ohta, MD, Masahiro Asaka, MD, Masahiro Imamura, MD

Blood (2005) 106 (11): 5367.

https://doi.org/10.1182/blood.V106.11.5367.5367

Published: 2005

Journal Articles

CD56 Expression Is the Potent Prognostic Marker of the Thalidomide Efficacy in the Patients with Multiple Myeloma.

Akio Mori, MD, PhD, Yutaka Tsutsumi, MD, PhD, Satoshi Hashino, MD, PhD, Hiroe Kanamori, MD, Makoto Ibata, MD, Shinobu Mashiko, MD, Nobuo Masauzi, MD, PhD, Masahiro Asaka, MD, PhD, Masahiro Imamura, MD, PhD

Blood (2005) 106 (11): 5142.

https://doi.org/10.1182/blood.V106.11.5142.5142

Published: 2005

Journal Articles

Effects of Imatinib Mesylate and Interferon-alpha Combined with Granulocyte Colony-Stimulating Factor on Chronic Myelogenous Leukemia Cells In Vitro .

Shuichi Ota, MD, Manabu Musashi, MD, Keiichi Kondo, MD, Nobuyasu Toyoshima, MD, Tomomi Toubai, MD, Noriaki Iwao, MD, Junji Tanaka, MD, Masahiro Asaka, MD, Masahiro Imamura, MD

Blood (2004) 104 (11): 4665.

https://doi.org/10.1182/blood.V104.11.4665.4665

Published: 2004

Journal Articles

Evaluation of MRD after Administration of Imatinib by Measurement of Real-Time Quantitative PCR-Based Major bcr/abl mRNA.

Mutsumi Takahata, MD, Satoshi Hashino, MD, Fumie Fujisawa, MD, Takeshi Kondo, MD, Syuichi Ota, MD, Sumiko Kobayashi, MD, Junji Tanaka, MD, Masahiro Imamura, MD, Masahiro Asaka, MD

Blood (2004) 104 (11): 4407.

https://doi.org/10.1182/blood.V104.11.4407.4407

Published: 2004

Journal Articles

Expansion of Inhibitory NK Receptor (CD94/NKG2A)-Expressing CD8 T Cells from Various Blood Mononuclear Cells with Cytolytic Activity Against Primary Leukemic Cells.

Junji Tanaka, MD, Noriaki Iwao, MD, Tomomi Toubai, MD, Yoko Miura, MD, Naoko Kato, MD, Akio Shigematsu, MD, Keichi Kondo, MD, Shuichi Ota, MD, Masahiro Asaka, MD, Masahiro Imamura, MD

Blood (2004) 104 (11): 4967.

https://doi.org/10.1182/blood.V104.11.4967.4967

Published: 2004

NARROW

A Chimeric Gene, FIP1L1-RARα, Is Isolated from t(4;17)-Positive Acute Promyelocytic Leukemia; a Report of Cloning and Functional Analysis.

Donor-Type Myelodysplastic Syndrome with t(2;3) and Monosomy 7 after Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-Type Aplastic Anemia.

HBV Reverse Seroconversion and Intervention with Vaccination after Allogeneic HSCT in Patients with Previous HBV Infection.

Chimeric Leukemic Protein PLZF/RARα Functions as an Adoptor for Cul3-Based E3 Ubiquitin Ligase To Regulate Proteosomal Degradation of RXRα.

Clinical Efficacy and Cost Benefit of Low-Dose Granulocyte Colony-Stimulating Factor after Standard Chemotherapy in Patients with Non-Hodgkin’s Lymphoma.

Expansion of Inhibitory NK Receptor (CD94/NKG2A)-Expressing Cytolytic CD8 T Cells and CD4 + CD25 + Regulatory T Cells from the Same Cord Blood.

Transition of Humoral Immunity and Clinical VZV Reactivation in Hematopoietic Stem Cell Transplantation Recipients.

Analysis of TREC (T Cell Receptor Excision Circles) Levels in CD94 Expressing CD8 T Cells in Chronic GVHD.

CD56 Expression Is the Potent Prognostic Marker of the Thalidomide Efficacy in the Patients with Multiple Myeloma.

Effects of Imatinib Mesylate and Interferon-alpha Combined with Granulocyte Colony-Stimulating Factor on Chronic Myelogenous Leukemia Cells In Vitro .

Evaluation of MRD after Administration of Imatinib by Measurement of Real-Time Quantitative PCR-Based Major bcr/abl mRNA.

Expansion of Inhibitory NK Receptor (CD94/NKG2A)-Expressing CD8 T Cells from Various Blood Mononuclear Cells with Cytolytic Activity Against Primary Leukemic Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only